Is United Therapeutics Corporation (UTHR) Going to Burn These Hedge Funds? – Taro Pharmaceutical Industries Ltd. (TARO), Endo Health Solutions Inc (ENDP)

Page 1 of 2

United Therapeutics Corporation (NASDAQ:UTHR) shareholders have witnessed a decrease in hedge fund interest of late.

United Therapeutics Corporation (NASDAQ:UTHR)

At the moment, there are a multitude of metrics market participants can use to monitor publicly traded companies. Two of the most useful are hedge fund and insider trading movement. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the top fund managers can outperform their index-focused peers by a very impressive amount (see just how much).

Just as integral, positive insider trading activity is another way to parse down the marketplace. As the old adage goes: there are plenty of reasons for a corporate insider to sell shares of his or her company, but only one, very simple reason why they would initiate a purchase. Several empirical studies have demonstrated the useful potential of this method if “monkeys” know what to do (learn more here).

Consequently, we’re going to take a glance at the latest action surrounding United Therapeutics Corporation (NASDAQ:UTHR).

How are hedge funds trading United Therapeutics Corporation (NASDAQ:UTHR)?

At the end of the fourth quarter, a total of 17 of the hedge funds we track were long in this stock, a change of -15% from the previous quarter. With hedge funds’ positions undergoing their usual ebb and flow, there exists a few notable hedge fund managers who were boosting their stakes meaningfully.

Of the funds we track, Sectoral Asset Management, managed by Jerome Pfund and Michael Sjostrom, holds the largest position in United Therapeutics Corporation (NASDAQ:UTHR). Sectoral Asset Management has a $78.8 million position in the stock, comprising 2.8% of its 13F portfolio. Sitting at the No. 2 spot is William Leland Edwards of Palo Alto Investors, with a $64.6 million position; 7.6% of its 13F portfolio is allocated to the company. Other peers with similar optimism include Matt Sirovich and Jeremy Mindich’s Scopia Capital, Ken Griffin’s Citadel Investment Group and Joel Greenblatt’s Gotham Asset Management.

Judging by the fact that United Therapeutics Corporation (NASDAQ:UTHR) has witnessed a declination in interest from the smart money, it’s safe to say that there was a specific group of funds who were dropping their positions entirely heading into 2013. Interestingly, Matt Sirovich and Jeremy Mindich’s Scopia Capital cut the biggest investment of the “upper crust” of funds we watch, worth about $97.7 million in call options, and Peter J. Eichler Jr. of Aletheia Research and Management was right behind this move, as the fund sold off about $20 million worth. These bearish behaviors are important to note, as aggregate hedge fund interest fell by 3 funds heading into 2013.

How have insiders been trading United Therapeutics Corporation (NASDAQ:UTHR)?

Insider purchases made by high-level executives is at its handiest when the company we’re looking at has experienced transactions within the past six months. Over the latest six-month time period, United Therapeutics Corporation (NASDAQ:UTHR) has seen 1 unique insiders purchasing, and 6 insider sales (see the details of insider trades here).

Let’s also review hedge fund and insider activity in other stocks similar to United Therapeutics Corporation (NASDAQ:UTHR). These stocks are The Medicines Company (NASDAQ:MDCO), Taro Pharmaceutical Industries Ltd. (NYSE:TARO), Endo Health Solutions Inc (NASDAQ:ENDP), Warner Chilcott Plc (NASDAQ:WCRX), and Cubist Pharmaceuticals Inc (NASDAQ:CBST). This group of stocks belong to the drug manufacturers – other industry and their market caps match UTHR’s market cap.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!